NO20043765L - Tricykliske triazolbenzazepinderivater, fremgangsmate til fremstilling derav, samt antiallergiske midler - Google Patents
Tricykliske triazolbenzazepinderivater, fremgangsmate til fremstilling derav, samt antiallergiske midlerInfo
- Publication number
- NO20043765L NO20043765L NO20043765A NO20043765A NO20043765L NO 20043765 L NO20043765 L NO 20043765L NO 20043765 A NO20043765 A NO 20043765A NO 20043765 A NO20043765 A NO 20043765A NO 20043765 L NO20043765 L NO 20043765L
- Authority
- NO
- Norway
- Prior art keywords
- antiallergic agents
- preparation
- alkyl
- benzazepine derivatives
- chem
- Prior art date
Links
- 239000000043 antiallergic agent Substances 0.000 title abstract 2
- -1 triazole benzazepine derivatives Chemical class 0.000 title 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000003884 phenylalkyl group Chemical group 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 1
- QDEVEJYEXBFIJD-UHFFFAOYSA-N triazolo[4,5-i][1]benzazepine Chemical class C1=CC2=CC=CC=NC2=C2C1=NN=N2 QDEVEJYEXBFIJD-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP26461197 | 1997-09-29 | ||
| JP5206398 | 1998-03-04 | ||
| PCT/JP1998/004363 WO1999016770A1 (en) | 1997-09-29 | 1998-09-29 | Tricyclic triazolobenzazepine derivatives, process for producing the same, and antiallergic |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20043765L true NO20043765L (no) | 2000-05-18 |
Family
ID=26392670
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20001500A NO319542B1 (no) | 1997-09-29 | 2000-03-23 | Tricykliske triazolbenzazepinderivater, fremgangsmate til fremstilling derav, samt antiallergiske midler |
| NO20043765A NO20043765L (no) | 1997-09-29 | 2004-09-08 | Tricykliske triazolbenzazepinderivater, fremgangsmate til fremstilling derav, samt antiallergiske midler |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20001500A NO319542B1 (no) | 1997-09-29 | 2000-03-23 | Tricykliske triazolbenzazepinderivater, fremgangsmate til fremstilling derav, samt antiallergiske midler |
Country Status (24)
| Country | Link |
|---|---|
| US (3) | US6372735B1 (no) |
| EP (1) | EP1026167B1 (no) |
| JP (1) | JP3188482B2 (no) |
| KR (1) | KR100389140B1 (no) |
| CN (2) | CN1312135C (no) |
| AT (1) | ATE233764T1 (no) |
| AU (1) | AU744636B2 (no) |
| BR (1) | BR9814055B1 (no) |
| CA (1) | CA2305307C (no) |
| DE (1) | DE69811930T2 (no) |
| DK (1) | DK1026167T3 (no) |
| ES (1) | ES2191963T3 (no) |
| HU (1) | HUP0004020A3 (no) |
| ID (1) | ID24101A (no) |
| IL (1) | IL135303A0 (no) |
| NO (2) | NO319542B1 (no) |
| NZ (1) | NZ503601A (no) |
| PL (1) | PL339544A1 (no) |
| PT (1) | PT1026167E (no) |
| RU (1) | RU2198885C2 (no) |
| SK (1) | SK283869B6 (no) |
| TR (1) | TR200000808T2 (no) |
| TW (1) | TW510902B (no) |
| WO (1) | WO1999016770A1 (no) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2346858T3 (es) * | 2001-12-26 | 2010-10-21 | Meiji Seika Kaisha Ltd. | Sustancia amorfa de un derivado triciclico de triazolobenzazepina. |
| ATE359277T1 (de) | 2002-02-01 | 2007-05-15 | Meiji Seika Kaisha | Verfahren zur herstellung einer 1,2,3- triazolverbindung |
| ATE543497T1 (de) | 2002-07-09 | 2012-02-15 | Bristol Myers Squibb Co | Substituierte heterozyklische derivate als mittel gegen diabetes und adipositas und verfahren |
| AU2003259131A1 (en) | 2002-07-09 | 2004-01-23 | Bristol-Myers Squibb Company | Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| JPWO2004113343A1 (ja) * | 2003-06-19 | 2006-08-31 | 明治製菓株式会社 | 三環性トリアゾロベンゾアゼピン誘導体の新規結晶性物質 |
| JPWO2004113451A1 (ja) * | 2003-06-20 | 2006-08-17 | 明治製菓株式会社 | 難溶性物質と水溶性高分子との共沈物およびその製造方法 |
| ATE381566T1 (de) | 2004-05-14 | 2008-01-15 | Millennium Pharm Inc | Verbindungen und verfahren zur inhibierung der mitotischen progression durch hemmung von aurorakinase |
| WO2007100079A1 (ja) | 2006-03-02 | 2007-09-07 | Meiji Seika Kaisha, Ltd. | 三環性トリアゾロベンゾアゼピン誘導体を含有する、アレルギー性眼疾患またはアレルギー性鼻疾患の予防または治療剤 |
| US8242105B2 (en) * | 2006-09-25 | 2012-08-14 | Forschungsverbund Berlin E.V. | Structural mimetics of proline-rich peptides and the pharmaceutical use thereof |
| CL2007003244A1 (es) * | 2006-11-16 | 2008-04-04 | Millennium Pharm Inc | Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer. |
| DE602008004820D1 (de) * | 2007-12-18 | 2011-03-17 | Meiji Seika Kaisha | Vorbeuge- oder heilmittel für entzündliche darmerkrankungen |
| ES2468391T3 (es) | 2008-12-22 | 2014-06-16 | Millennium Pharmaceuticals, Inc. | Combinación de inhibidores de cinasas Aurora y anticuerpos anti-CD20 |
| JO3635B1 (ar) | 2009-05-18 | 2020-08-27 | Millennium Pharm Inc | مركبات صيدلانية صلبة وطرق لانتاجها |
| ES2768295T3 (es) * | 2010-01-07 | 2020-06-22 | Alkermes Pharma Ireland Ltd | Profármacos de compuestos heteroaromáticos |
| JP2013520424A (ja) | 2010-02-19 | 2013-06-06 | ミレニアム ファーマシューティカルズ， インコーポレイテッド | ナトリウム４−｛［９−クロロ−７−（２−フルオロ−６−メトキシフェニル）−５Ｈ−ピリミド［５，４−ｄ］［２］ベンゾアゼピン−２−イル］アミノ｝−２−メトキシベンゾエートの結晶形 |
| US20130303519A1 (en) | 2012-03-20 | 2013-11-14 | Millennium Pharmaceuticals, Inc. | Methods of treating cancer using aurora kinase inhibitors |
| WO2014153509A1 (en) | 2013-03-22 | 2014-09-25 | Millennium Pharmaceuticals, Inc. | Combination of catalytic mtorc 1/2 inhibitors and selective inhibitors of aurora a kinase |
| WO2017015316A1 (en) | 2015-07-21 | 2017-01-26 | Millennium Pharmaceuticals, Inc. | Administration of aurora kinase inhibitor and chemotherapeutic agents |
| AR114070A1 (es) * | 2017-12-29 | 2020-07-15 | Biomarin Pharm Inc | Inhibidores de glicolato oxidasa para el tratamiento de una enfermedad |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69411243T2 (de) | 1993-04-16 | 1998-11-19 | Shionogi & Co | Verfahren zur herstellung eines lignan-derivats |
| ES2156933T3 (es) | 1993-12-28 | 2001-08-01 | Meiji Seika Co | Derivados triciclicos de benzazepina y benzotiazepina. |
| JP3537446B2 (ja) * | 1995-06-15 | 2004-06-14 | 明治製菓株式会社 | 三環性ベンゾアゼピン化合物 |
| NZ330973A (en) * | 1996-03-08 | 2000-03-27 | Zeneca Ltd | Azolobenzazepine derivatives as neurologically active agents |
| US20070059533A1 (en) * | 2005-09-12 | 2007-03-15 | Burdette Steven R | Thermal reflow of glass and fused silica body |
-
1998
- 1998-09-29 IL IL13530398A patent/IL135303A0/xx unknown
- 1998-09-29 AU AU91869/98A patent/AU744636B2/en not_active Ceased
- 1998-09-29 TW TW087116198A patent/TW510902B/zh not_active IP Right Cessation
- 1998-09-29 SK SK425-2000A patent/SK283869B6/sk unknown
- 1998-09-29 EP EP98944289A patent/EP1026167B1/en not_active Expired - Lifetime
- 1998-09-29 PL PL98339544A patent/PL339544A1/xx unknown
- 1998-09-29 CA CA002305307A patent/CA2305307C/en not_active Expired - Fee Related
- 1998-09-29 JP JP51996999A patent/JP3188482B2/ja not_active Expired - Fee Related
- 1998-09-29 NZ NZ503601A patent/NZ503601A/en unknown
- 1998-09-29 DE DE69811930T patent/DE69811930T2/de not_active Expired - Lifetime
- 1998-09-29 BR BRPI9814055-8A patent/BR9814055B1/pt not_active IP Right Cessation
- 1998-09-29 CN CNB2003101047539A patent/CN1312135C/zh not_active Expired - Fee Related
- 1998-09-29 DK DK98944289T patent/DK1026167T3/da active
- 1998-09-29 TR TR2000/00808T patent/TR200000808T2/xx unknown
- 1998-09-29 AT AT98944289T patent/ATE233764T1/de active
- 1998-09-29 CN CNB98810735XA patent/CN1155599C/zh not_active Expired - Fee Related
- 1998-09-29 RU RU2000111517/04A patent/RU2198885C2/ru not_active IP Right Cessation
- 1998-09-29 ID IDW20000808A patent/ID24101A/id unknown
- 1998-09-29 HU HU0004020A patent/HUP0004020A3/hu unknown
- 1998-09-29 US US09/509,494 patent/US6372735B1/en not_active Expired - Lifetime
- 1998-09-29 KR KR10-2000-7003362A patent/KR100389140B1/ko not_active Expired - Fee Related
- 1998-09-29 ES ES98944289T patent/ES2191963T3/es not_active Expired - Lifetime
- 1998-09-29 PT PT98944289T patent/PT1026167E/pt unknown
- 1998-09-29 WO PCT/JP1998/004363 patent/WO1999016770A1/ja not_active Ceased
-
2000
- 2000-03-23 NO NO20001500A patent/NO319542B1/no unknown
-
2002
- 2002-02-13 US US10/073,326 patent/US7022860B2/en not_active Expired - Fee Related
-
2004
- 2004-09-08 NO NO20043765A patent/NO20043765L/no not_active Application Discontinuation
-
2005
- 2005-11-09 US US11/269,828 patent/US7238812B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20001500D0 (no) | Tricykliske triazolbenzazepinderivater, fremgangsmåte til fremstilling derav, samt antiallergiske midler | |
| DK1029853T3 (da) | Heteroaromatiske bicykliske derivativer, der er egnede som anticancermidler | |
| DK0928788T3 (da) | Imidazolidin-4-on-derivater, der er nyttige som anticancer-midler | |
| BG106340A (en) | Substituted oxoazaheterocyclyl compounds | |
| TW283624B (no) | ||
| NZ519241A (en) | Tricyclic fused heterocyclic compound, process for preparing it and medicament comprising it | |
| EP0902007A4 (en) | CHALCONE DERIVATIVES AND MEDICINES CONTAINING THEM | |
| HUT74182A (en) | Novel imidazole derivatives, process for producing the same and pharmaceutical compositions containing the compounds | |
| DK0918776T3 (da) | Totalsyntese af antitumor acylfulvener | |
| ATE271045T1 (de) | Sauerstoffhaltige heterocyclische verbindungen | |
| AU3415599A (en) | Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor agents | |
| PL359415A1 (en) | Oxadiazole derivatives having anticancer effects | |
| EP1094055A4 (en) | NEW VINYLBENZENE DERIVATIVES | |
| NZ332923A (en) | Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents | |
| NO20003604L (no) | Nye tricykliske forbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem | |
| AR017971A1 (es) | DERIVADOS TRICíCLICOS DE TRIAZOLBENZAZEPINAS, PROCEDIMIENTO PARA PRODUCIR LOS MISMOS, COMPOSICIONES FARMACEUTICAS FORMULADAS CON DICHOS COMPUESTOS Y COMPUESTOS INTERMEDIARIOS DE APLICACION EN DICHO PROCEDIMIENTO Y LA PEPARACION DE LOS MISMOS. | |
| EP0798304A4 (en) | DRUGS AGAINST TRHOMBOCYTOPENIA | |
| EP0502488A3 (en) | Phosphorus-containing azetidin-2-one derivatives | |
| EP1251129A4 (en) | PYRIMIDINE DERIVATIVES WITH ANTI-TUMOR EFFECT | |
| MX9704976A (es) | Derivados de 1,2,3-benzotiadiazol. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |